Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2021 / Cilt: 55 - Sayı: 4

Acute-Phase Stroke Outcome and Lipids

Pages
[538]–544
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Serum TG level may be a better indicator for mortality in the acute hypercatabolic trauma such as stroke.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of the study is to investigate the relationship of lipid subgroups with short-term mortality in acute stroke (AS).
📊
Key Findings & Data:Methods: This retrospective study included 698 patients with AS who presented within 24 h of symptom onset.
💡
Conclusion & Impact:Serum TG level may be a better indicator for mortality in the acute hypercatabolic trauma such as stroke.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: The aim of the study is to investigate the relationship of lipid subgroups with short-term mortality in acute stroke (AS). Methods: This retrospective study included 698 patients with AS who presented within 24 h of symptom onset. A hemogram from peripheral venous blood samples was taken at admission. Total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), TC/HDL-C rate, and TG/HDL-C rate were recorded. Duration of follow-up was defined as 30 days. Results: 64 out of 698 patients died during the follow-up period. The mean TG, TG/HDL-C, and TC/HDL-C levels were significantly lower in the mortality group than the survival group. In the receiver operating characteristic (ROC) analysis, the cutoff values and area under the curve of the TG, TG/HDL-C, TC, and TC/HDL-C levels for short-term stroke mortality are as follows ([100.2 mg/dL, 0.648]; [2.52, 0.650]; [170.50 mg/dL, 0.598]; and [4.32, 0.640], respectively). In the Cox regression model, only TG and TG/HDL-C, according to their ROC cutoff values, were independent variables as short-term mortality predictors (TG ≤100.2 mg/dL, HR:2.413 , 95% CI: 1.345–4.327, P:0.004); (TG/HDL ≤2.56, HR: 2.720, 95% CI: 1.389–5.359, P:0.003, respectively). Conclusion: Dyslipidemia is a well-known as a risk factor of stroke. However, this study focused on the estimation that lower TG and TG/HDL-C levels at the time of hospital admission might be predictors of short-term mortality within a month of AS attack, which is a different subject from long term risk factors of stroke. Serum TG level may be a better indicator for mortality in the acute hypercatabolic trauma such as stroke.

🔖

Cite This Article

TOKGÖZ, O. S., GUNEY, F., KAYA, A., BUĞRUL, A., ERUYAR, E., BÜYÜKGÖL, H., SEYİTHANOGLU, A., İYİSOY, M. S. (2021). Acute-Phase Stroke Outcome and Lipids. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 55 - Sayı: 4, [538]–544. https://ajindex.com/articles/398692

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Hankey GJ. Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis 2003;16 Suppl 1:14–9
  2. Deng QW, Li S, Wang H, Lei L, Zhang HQ, Gu ZT, et al. The shortterm prognostic value of the triglyceride-to-high-density lipoprotein cholesterol ratio in acute ischemic stroke. Aging Dis 2018;9:498–506
  3. Pearson TA. Understanding the impact of hyperlipidemia treatment on medical expenditures for cardiovascular disease. Med Care 2017;55:1–3
  4. Yi SW, Shin DH, Kim H, Yi JJ, Ohrr H. Total cholesterol and stroke mortality in middle-aged and elderly adults: A prospective cohort study. Atherosclerosis 2018;270:211–7
  5. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al; SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987–1003
  6. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117:743–53
  7. Rapp RJ. Hypertriglyceridemia: a review beyond low-density lipoprotein. Cardiol Rev 2002;10:163–72
  8. Chang JJ, Katsanos AH, Khorchid Y, Dillard K, Kerro A, Burgess LG, et al. Higher low-density lipoprotein cholesterol levels are associated with decreased mortality in patients with intracerebral hemorrhage. Atherosclerosis 2018;269:14–20
  9. McKinney JS, Kostis WJ. Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials. Stroke 2012;43:2149–56
  10. Choi JS, Song YM, Sung J. Serum total cholesterol and mortality in middle-aged Korean women. Atherosclerosis 2007;192:445–7
  11. Zhang Y, Tuomilehto J, Jousilahti P, Wang Y, Antikainen R, Hu G. Total and high-density lipoprotein cholesterol and stroke risk. Stroke 2012;43:1768–74
  12. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al; INTERSTROKE investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010;376:112–23
  13. Prospective Studies Collaboration, Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007;370:1829–39
  14. Wang X, Dong Y, Qi X, Huang C, Hou L. Cholesterol levels and risk of hemorrhagic